Overview
Thomas Carlier practices practicing medicine in Nantes, France.
Mr. Carlier is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Smoldering Multiple Myeloma, Multiple Myeloma, Mantle Cell Lymphoma (MCL), Medullary Thyroid Carcinoma, and Liver Embolization.
He is actively involved in clinical research, co-authoring 71 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Thomas Carlier
Is Thomas Carlier a top-rated expert for Smoldering Multiple Myeloma?
MediFind is an objective health platform that identifies experts based on real-world data. Thomas Carlier is classified as an Advanced expert for Smoldering Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Thomas Carlier participate in research or clinical trials?
Yes. Thomas Carlier has published 71 articles and abstracts on conditions like Smoldering Multiple Myeloma. You can view a list of Thomas Carlier's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Mantle Cell Lymphoma (MCL)Mr. Carlier isAdvanced. Learn about Mantle Cell Lymphoma (MCL).
- Multiple MyelomaMr. Carlier isAdvanced. Learn about Multiple Myeloma.
- Smoldering Multiple MyelomaMr. Carlier isAdvanced. Learn about Smoldering Multiple Myeloma.
- Experienced
- B-Cell LymphomaMr. Carlier isExperienced. Learn about B-Cell Lymphoma.
- Breast CancerMr. Carlier isExperienced. Learn about Breast Cancer.
- Chronic T-Cell Leukemia (CTCL)Mr. Carlier isExperienced. Learn about Chronic T-Cell Leukemia (CTCL).
- Diffuse Large B-Cell Lymphoma (DLBCL)Mr. Carlier isExperienced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- EndocarditisMr. Carlier isExperienced. Learn about Endocarditis.
- Ewing SarcomaMr. Carlier isExperienced. Learn about Ewing Sarcoma.
- Hodgkin LymphomaMr. Carlier isExperienced. Learn about Hodgkin Lymphoma.
- Infective EndocarditisMr. Carlier isExperienced. Learn about Infective Endocarditis.
- Liver EmbolizationMr. Carlier isExperienced. Learn about Liver Embolization.
- Lung MetastasesMr. Carlier isExperienced. Learn about Lung Metastases.
- Medullary Thyroid CarcinomaMr. Carlier isExperienced. Learn about Medullary Thyroid Carcinoma.
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Neuroendocrine TumorMr. Carlier isExperienced. Learn about Neuroendocrine Tumor.
- Non-Hodgkin LymphomaMr. Carlier isExperienced. Learn about Non-Hodgkin Lymphoma.
- Osteolysis Syndrome RecessiveMr. Carlier isExperienced. Learn about Osteolysis Syndrome Recessive.
- PlasmacytomaMr. Carlier isExperienced. Learn about Plasmacytoma.
- Prolymphocytic LeukemiaMr. Carlier isExperienced. Learn about Prolymphocytic Leukemia.
- Thyroid CancerMr. Carlier isExperienced. Learn about Thyroid Cancer.